• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 21; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ONX AORTIC CONFORM EXT 21; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXACE-21
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Endocarditis (1834)
Event Date 06/23/2023
Event Type  Injury  
Event Description
According to the initial report an aortic implant registration card was received for a onxace-21 that is for a patient with an existing aortic implant.The onxace-21 sn: (b)(6) was implanted on (b)(6) 2023.It was then explanted on (b)(6) 2023.Additional information provided from the surgeon is as follows "i explanted the valve so i could do a redo avr/mvr for mitral valve endocarditis (culture negative).I put another on-x back in the aortic position and put an on-x mechanical in the mitral.The old dehisced valve was a st.Jude.There was nothing wrong with the on-x aortic valve.I just took it out for exposure purposes and i could not say that it was not infected.It looked perfect and it was functioning perfectly too.Valve was not saved.Patient is doing great." no additional information forthcoming.
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Manufacturer Narrative
The manufacturing records for the onxace-21 sn: (b)(6) were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were noted.Change order(s) for leaflet tuning are performed as a part of the standard manufacturing process.On (b)(6) 2023 an onxace-21 sn (b)(6) was used in a case for a 63-year-old female in the aortic position.A second aortic on-x was reported to device tracking on (b)(6) 2023 as implanted in the same position, same patient: (b)(6) 2023 onxace-21 sn (b)(6) (150 days post-implant).Additional information was obtained from the surgeon; however, the valve was not returned for inspection.The statement from the surgeon is as follows "i explanted the valve so i could do a redo avr/mvr for mitral valve endocarditis (culture negative).I put another on-x back in the aortic position and put an on-x mechanical in the mitral.The old dehisced valve was a st.Jude.There was nothing wrong with the on-x aortic valve.I just took it out for exposure purposes, and i could not say that it was not infected.It looked perfect and it was functioning perfectly too.Valve was not saved.Patient is doing great." review of manufacturing records show no processing issues with the original valve and with the statement from the surgeon we can say that the on-x aortic valve itself did not contribute to the explantation.The valve was explanted during an avr/mvr redo secondary to mitral valve endocarditis and the surgeon could not definitively state there was no infection of the aortic valve when it was removed to facilitate the replacement of the infected mitral valve.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Event Description
According to the initial report an aortic implant registration card was received for a onxace-21 that is for a patient with an existing aortic implant.The onxace-21 sn: (b)(6) was implanted on (b)(6) 2023.It was then explanted on (b)(6) 2023.Additional information provided from the surgeon is as follows "i explanted the valve so i could do a redo avr/mvr for mitral valve endocarditis (culture negative).I put another on-x back in the aortic position and put an on-x mechanical in the mitral.The old dehisced valve was a st.Jude.There was nothing wrong with the on-x aortic valve.I just took it out for exposure purposes and i could not say that it was not infected.It looked perfect and it was functioning perfectly too.Valve was not saved.Patient is doing great." no additional information forthcoming.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONX AORTIC CONFORM EXT 21
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd. nw
kennesaw, GA 30144
7704193355
MDR Report Key17558987
MDR Text Key321277297
Report Number1649833-2023-00029
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier00851788001457
UDI-Public851788001457
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/16/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberONXACE-21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/02/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age64 YR
Patient SexFemale
-
-